Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of osimertinib analogue that selectively inhibits EGFR for NSCLC treatment

Jan. 2, 2019

Methylscape alteration of DNA physicochemical properties can be applied for cancer diagnostic assays

Jan. 2, 2019

Umbralisib plus ibrutinib demonstrate safety and activity in patients with leukemia and lymphoma

Jan. 2, 2019

National Health Research Institutes reports development of tyrosine kinase inhibitors

Dec. 31, 2018

Tianjin Zhongxin Pharmaceutical Research Center reports agents for treatment of cancer

Dec. 31, 2018

PTC Therapeutics patents compounds for Huntington's disease

Dec. 31, 2018

Bristol-Myers Squibb describes formyl peptide receptor agonists

Dec. 31, 2018

Anti-RSV compounds reported in Enanta Pharmaceuticals patent

Dec. 31, 2018

University of Southern California patent describes agents for imaging ADP-ribosylation

Dec. 31, 2018

InventisBio and Betta Pharma sign Chinese agreement for D-0316

Dec. 31, 2018